Inventor
NINKOVIC SACHA
US23 patents
⚠️ This page may combine multiple inventors who share the name “NINKOVIC SACHA”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
PFIZER
15 patentsUS10766884B2Sep 8, 2020
Cyclin dependent kinase inhibitors
PFIZER19 citations92
US10233188B2Mar 19, 2019
CDK2/4/6 inhibitors
PFIZER13 citations92
US11220494B2Jan 11, 2022
Cyclin dependent kinase inhibitors
PFIZER13 citations84
US11014911B2May 25, 2021
CDK2 inhibitors
PFIZER11 citations84
US9040515B2May 26, 2015
Aryl and heteroaryl fused lactams
PFIZER13 citations82
US11773082B2Oct 3, 2023
CDK2 inhibitors
PFIZER2 citations71
US11718603B2Aug 8, 2023
CDK2 inhibitors
PFIZER3 citations71
US10246433B2Apr 2, 2019
Aryl and heteroaryl fused lactams
PFIZER5 citations71
US12378232B2Aug 5, 2025
Cyclin dependent kinase inhibitors
PFIZER0 citations61
US11396512B2Jul 26, 2022
CDK2/4/6 inhibitors
PFIZER0 citations60
US9328096B2May 3, 2016
Tropomyosin-related kinase inhibitors
PFIZER2 citations60
US10800783B2Oct 13, 2020
CDK2/4/6 inhibitors
PFIZER0 citations49
US9873690B2Jan 23, 2018
3-indol substituted derivatives, pharmaceutical compositions and methods for use
PFIZER1 citations49
US10544095B2Jan 28, 2020
3-indol substituted derivatives, pharmaceutical compositions and methods for use
PFIZER0 citations38
US9593097B2Mar 14, 2017
Axl inhibitors
PFIZER0 citations38
SCRIPPS RESEARCH INST
4 patentsUS6441186B1Aug 27, 2002
Epothilone analogs
SCRIPPS RESEARCH INST88 citations96
US6380394B1Apr 30, 2002
Epothilone analogs
SCRIPPS RESEARCH INST107 citations96
US6660758B1Dec 9, 2003
Epothilone analogs
SCRIPPS RESEARCH INST45 citations91
US7173137B2Feb 6, 2007
Epothilone analogs
SCRIPPS RESEARCH INST7 citations72
AGOURON PHARMA
3 patentsUS7462713B2Dec 9, 2008
Tricyclic compounds protein kinase inhibitors for enhancing the efficacy of anti-neoplastic agents and radiation therapy
AGOURON PHARMA18 citations90
US7132533B2Nov 7, 2006
Tricyclic compounds protein kinase inhibitors for enhancing the efficacy of anti-neoplastic agents and radiation therapy
AGOURON PHARMA21 citations90
US6967198B2Nov 22, 2005
Tricyclic compounds protein kinase inhibitors for enhancing the efficacy of anti-neoplastic agents and radiation therapy
AGOURON PHARMA17 citations90